Target price, page-53

First 53 Last

Share
Profile

Follow
aussilver

972 Posts.

107

05/03/17

11:45

Post #: 23106737
Share

Originally posted by AmbiGuity ↑

Hi PH6,

Thanks for your welcome back.

Same posts, same(ish) posters hey? But if enough people call them out on their bullsh1t, these forums will be better off.

I've been seeing the same thing, SP rises based on hype (and whispers), and it just screams BEWARE to me.

I agree with you again with sustained SP rises, rises will only been sustained with news of realised revenue, not on news of potential revenue, and let's face it, which of the esteemed MC companies are generating decent revenue? Profit? Years off, and yet some posters are encouraging others to bet the house on certain stocks....amazingly stupid. Newton must be turning in his grave. Posters expecting immediate gains may be sorely mistaken. "What goes up...." Don't get me wrong, this is the growth sector, but it's infantile, and there is plenty of time for investors to jump on board. Informed investors should have time to investigate which of the ASX companies will be commercially viable without posters ramming a FOMO down their throats.

Have some other thoughts that I'll post on that other forum in due course (it crossed back into buy territory today, and looks solid). Exciting times ahead especially when one has done some further research on import/export licenses with the SA scheme.

Good luck to you good, and medicated Sir.

Expand

Trying to make sense of this,are you referring to the same stock ?
you say

"I've been seeing the same thing, SP rises based on hype (and whispers), and it just screams BEWARE to me."

Then this

"Have some other thoughts that I'll post on that other forum in due course (it crossed back into buy territory today, and looks solid)"

AC8 Price at posting: 37.5¢ Sentiment: Sell Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

OJC

SPC to merge with Original Juice Co and Nature One Dairy

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 769 more messages in this thread...

First 53 Last

Add AC8 (ASX) to my watchlist

Target price, page-53

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News